Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Product 55394 in the Treatment of Bacterial Vaginosis

NCT01621399 is registered in ClinicalTrials.gov with Medicis Global Service Corporation as lead sponsor.

NCT NCT01621399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01621399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Randomized, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of Product 55394 in the Treatment of Bacterial Vaginosis
Lead sponsor
Medicis Global Service Corporation
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2012
Completion date
December 31, 2012
Enrollment
651 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis